Scaling and root planning (SRP) is the gold standard for non-surgical periodontal treatment. Green tea as a supporting alternative in non-surgical periodontal treatment has been suggested as a therapeutic option in the treatment of periodontitis.
 
  To analyse the comparative effectiveness of green tea (Camellia sinensis) in its different forms and applications for the treatment of periodontitis.
 
  We included randomized clinical trials evaluating green tea as an adjuvant therapeutic agent to scaling and root planning (SRP) in the treatment of periodontitis. For the meta-analysis, we calculated standardized mean difference (SMD) and 95%CI comparing green tea and control (only SRP). We subgrouped by types of application forms of green tea. The certainty of the evidence was assessed through GRADE.
 
  Nine studies were included. The follow-up time of treatments varied from 21days to 6months. The subgroup meta-analysis showed that the green tea as sachet reduced probing bleeding (SMD=-0.71; 95%CI) and the gingival index (SMD=-0.78; 95%CI) compared to SRP with very low certainty of evidence. The sachet (SMD=-0.29; 95%CI)and dentifrice (SMD=-1.31; 95%CI) reduced plaque index with very low certainty compared to the control. All forms of application of green tea showed very low certainty of evidence (SMD=-0.27; 95% CI) in reducing the probing depth, as well as for the loss of clinical insertion (SMD=-0.42; 95% CI) with low certainty of evidence.
 
  There was not a difference in the effectiveness of green tea isolated or in combination with SRP to reduce probing depth. Green tea adjunct to periodontal therapy showed very low certainty of effectiveness for the treatment of periodontal disease.
 There was not a difference in the effectiveness of green tea isolated or in combination with SRP to reduce probing depth. Green tea adjunct to periodontal therapy showed very low certainty of effectiveness for the treatment of periodontal disease.
  Accurate estimation of antimicrobial use (AMU) is important in assessing reduction of agricultural AMU. This cross-sectional study aimed to evaluate several approaches for estimating AMU at the herd level and to report on AMU for beef and dairy farms in Scotland.
 
  Pharmaceutical sales data for 75 cattle herds (2011-2015) were screened for antimicrobial products and aggregated by herd and year. Several denominators for usage estimates were calculated and compared for their suitability at the herd level.
 
  The median total mass of active ingredient sold per kg of bovine livestock was 9.5mg/kg for beef herds and 14.3mg/kg for dairy herds. The 'highest priority critically important' antimicrobials (HPCIA) were by total mass of active ingredient, 10.6% of all sales; by total defined daily dose veterinary (DDDVet), 29.8% and by DCDvet, 20.0%. These are the first estimates of AMU for beef cattle in the UK, and for cattle of any kind in Scotland. Estimates of herd-level usage based on population correction unit (PCU) were sensitive to low values for PCU for specific herd-years due to their demographic composition.
 
  Pharmaceutical sales data can provide useful estimates of AMU, but estimating usage per PCU is not appropriate for comparing groups of cattle with different demographic compositions or for setting herd-level targets. Total mass of active ingredient per kilogram of livestock is more stable and hence suitable than PCU-based methods for assessing AMU at the herd level.
 Pharmaceutical sales data can provide useful estimates of AMU, but estimating usage per PCU is not appropriate for comparing groups of cattle with different demographic compositions or for setting herd-level targets. Total mass of active ingredient per kilogram of livestock is more stable and hence suitable than PCU-based methods for assessing AMU at the herd level.Theories of autobiographical memory distinguish between involuntary and voluntary memories. While involuntary memories are retrieved with no conscious intention and are therefore unexpected, voluntary memories are both intended and expected. Recent research has shown that participants sometimes classify their memories as either involuntary or voluntary based on retrieval effort instead of intention. These findings question whether intention really is the defining difference between these two types of retrieval or whether retrieval effort is also an important determinant. In two experimental studies, we investigated the extent to which participants rely on retrieval effort while classifying their memories as involuntary or voluntary. We created experimental conditions that maximize the probability of one type of retrieval while minimizing the probability of another type. Participants reported autobiographical memories in each condition while the programme registered their retrieval time. They then classified their memories as either voluntary or involuntary and rated all memories on perceived retrieval effort. This gave us four categories of memories experimentally defined voluntary and involuntary memories with an objective measure of effort (retrieval time) and subjectively classified involuntary and voluntary memories with a subjective measure of effort. This allowed us to investigate the relative contribution of intention and effort to involuntary and voluntary memories. We replicated and extended previous findings by showing that the majority of memories were classified as involuntary independently of whether they were retrieved in the experimentally defined voluntary or involuntary condition.  https://www.selleckchem.com/products/almorexant-hcl.html  This could indicate that subjective effort is more important than intention for the involuntary-voluntary distinction in contrast with existing theories. We discuss theoretical and methodological implications of this finding.Antibodies are a key element of the immune response. They can bind their molecular targets with exquisite sensitivity and specificity, providing protection against a multitude of pathogens. They have long been understood to be markers of a successful response to vaccination, and are now widely manufactured as highly specific and robust immunotherapeutic agents. Less well understood are the polyreactive antibodies, found in serum, which are able to bind more than one target molecule. Here, we highlight new research into these naturally occurring polyreactive antibodies, which demonstrates their importance for protection against Streptococcus pneumoniae, a common cause of airway infection.